News

• Replimune Releases Updated Corporate Presentation
  22:01 - GlobeNewswire
•  
• Agenus to Report Third Quarter Earnings
  16:34 - GlobeNewswire
•  
• GigaGen Announces Publication in the Peer-Reviewed Journal mAbs
  16:17 - GlobeNewswire
•  
• PTA-News: 4SC AG: 4SC provides Q3 business update and outlook
  07:30 - pressetext
•  
• Replimune Appoints Tanya Lewis to the Board of Directors
  10/19/2020 / 22:01 - GlobeNewswire
•  
• Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)
  10/19/2020 / 13:00 - GlobeNewswire
•  
• NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inhibiting ILT2 and ILT4
  10/19/2020 / 13:00 - GlobeNewswire
•  
• Microsoft is Most Imitated Brand for Phishing Attempts in Q3 2020
  10/19/2020 / 12:00 - GlobeNewswire
•  
• New Mechanism of Action Data for NT219 Presented at Epigenetics and Metabolism AACR Special Virtual Conference
  10/16/2020 / 13:21 - GlobeNewswire
•  
• PTA-News: Medigene AG: Three Medigene poster presentations at SITC Annual Meeting
  10/15/2020 / 22:00 - pressetext
•  
• Fate Therapeutics Announces Presentations at the 2020 Society for Immunotherapy of Cancer Annual Meeting
  10/15/2020 / 14:00 - GlobeNewswire
•  
• OncXerna Therapeutics to Participate at the Jefferies Virtual London Healthcare Conference
  10/15/2020 / 13:10 - GlobeNewswire
•  
• Genocea Announces Upcoming Data Presentations at Virtual SITC 2020
  10/14/2020 / 23:22 - GlobeNewswire
•  
• Agenus to Present on Seven Novel Programs at SITC 2020
  10/14/2020 / 23:00 - GlobeNewswire
•  
• BioNTech to Present Data from BNT311 (GEN1046) and BNT131 (SAR441000) Programs at SITC 35th Annual Meeting
  10/14/2020 / 23:00 - GlobeNewswire